Human medicines European public assessment report (EPAR): Pifeltro, doravirine, HIV Infections, Date of authorisation: 22/11/2018, Revision: 9, Status: Authorised
Pifeltro is an antiviral medicine used to treat adults and adolescents from 12 years of age weighing at least 35 kg who are infected with human immunodeficiency virus type 1 (HIV-1), a virus that causes acquired immune deficiency syndrome (AIDS). Pifeltro is used together with other antiviral medicines.
It is only used in patients where the virus has not developed resistance to medicines that work in the same way as Pifeltro.
Pifeltro contains the active substance doravirine.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
